CoChat

Differential Response to Lithium and Carbamazepine in the Prophylaxis of Bipolar Disorder

Greil, Waldemar, Kleindienst Nikolaus, Dipl-Stat, Erazo Natalia, Dipl-Psych, Muller-Oerlinghausen, Bruno · 1998 · Journal of Clinical Psychopharmacology

The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.

Abstract

In a randomized, prospective, multicenter study with an observation period of 2.5 years, the differential prophylactic efficacy of lithium versus carbamazepine was compared in 171 patients fulfilling DSM-IV criteria for bipolar disorder. Serum drug levels were 0.6+/-0.1 mmol/L for lithium and 6.1+/-1.3 microg/mL for carbamazepine. Patients were subdivided into a classical subgroup (bipolar I patients without mood-incongruent delusions and without comorbidity, N = 67) and a nonclassical subgroup including all other patients (N = 104). Classical bipolar patients had a lower rehospitalization rate with lithium than with carbamazepine prophylaxis (p = 0.005). For the nonclassical group, a trend in favor of carbamazepine was found. In the lithium group, there was a positive association between hospitalization rate and number of nonclassical features (bipolar II/not otherwise specified, mood-incongruent delusions, comorbidity; p = 0.035). For carbamazepine, this association was negative (p = 0.033). Analyses including mixed states as an additional nonclassical feature confirmed the results. In conclusion, lithium seems to be superior to carbamazepine in treating classical bipolar cases. Patients with nonclassical features might profit more from prophylaxis with carbamazepine, which seems to have a broader spectrum of activity.

Overview

Integrity signals

Registry

Crossref · 10.1097/00004714-199812000-00007

Cites

29 of 29 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 29 references

Research works printed but not linked: 6

  1. Schou, 1993, Lithium, 4, 77
  2. Gelenberg, 1993, Psychopharmacol Bull, 29, 447
  3. Prien, 1990, Psychopharmacol Bull, 26, 409
  4. Solomon, 1995, J Clin Psychiatry, 56, 5
  5. Angst, 1981, Bibl Psychiatr, 161, 32
  6. Placidi, 1986, J Clin Psychiatry, 47, 490

Cited by

See all 206

Metadata

Authors
Greil, W., Kleindienst Nikolaus, D.-S., Erazo Natalia, D.-P., & Muller-Oerlinghausen, B.
Affiliations
Sanatorium Kilchberg (CH)
Venue
Journal of Clinical Psychopharmacology
Published
1998-12
Volume
18
Issue
6
Pages
455-460
ISSN
0271-0749 (ISSN-L)
OpenAlex
W2028464981
Cited by
206
References
28
Citations by year
2025: 1 · 2024: 3 · 2021: 4 · 2020: 2 · 2019: 8 · 2018: 5 · 2017: 5 · 2016: 6 · 2015: 3 · 2014: 3 · 2013: 6 · 2012: 7
FWCI
5.46
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Clinical Psychopharmacology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
  • Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
Keywords
bipolar disorder, lithium, carbamazepine, relapse prevention, hospital readmission, comorbidities, mixed states, serum drug concentration
MeSH terms
Adolescent, Adult, Aged, Bipolar Disorder, Carbamazepine, Female, Humans, Lithium, Male, Middle Aged, Prospective Studies, Treatment Outcome, Antimanic Agents, Chemoprevention

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Differential Response to Lithium and Carbamazepine in the Prophylaxis of Bipolar Disorder. https://app.cochat.ai/papers/10.1097/00004714-199812000-00007
The paper
Greil, W., Kleindienst Nikolaus, D.-S., Erazo Natalia, D.-P., & Muller-Oerlinghausen, B. (1998). Differential Response to Lithium and Carbamazepine in the Prophylaxis of Bipolar Disorder. Journal of Clinical Psychopharmacology. https://doi.org/10.1097/00004714-199812000-00007

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.